Firms vie to treat genetic disease

From Philadelphia, at the annual meeting of the American Society of Human Genetics

Genzyme stands at the center of another enzyme-replacement story. The rare, fatal genetic condition in this instance is Fabry’s disease. In people with the illness, lack of the enzyme alpha-galactosidase A results in an abnormal buildup of certain lipids in blood vessel cells.